Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05238883 |
|---|---|
| Brief Title: | A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors |
| First Submitted : | December 16, 2021 |
| First Submitted that Met QC Criteria : | February 9, 2022 |
| First Posted : | February 14, 2022 |
| Last Update Submitted that Met QC Criteria : | April 29, 2024 |
| Last Update Posted : | May 1, 2024 |